Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of “Hold” by Brokerages
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has been given a consensus rating of “Hold” by the fourteen analysts that are covering the company, MarketBeat.com reports. Ten analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among […]
More Stories
Comerica (NYSE:CMA) Price Target Increased to $66.00 by Analysts at Truist Financial
Comerica (NYSE:CMA – Free Report) had its price objective lifted by Truist Financial from $53.00 to $66.00 in a report...
Grand Canyon Education (NASDAQ:LOPE) Receives Outperform Rating from Barrington Research
Barrington Research restated their outperform rating on shares of Grand Canyon Education (NASDAQ:LOPE – Free Report) in a research report...
Bank OZK (NASDAQ:OZK) Price Target Cut to $48.00
Bank OZK (NASDAQ:OZK – Free Report) had its price objective trimmed by Truist Financial from $49.00 to $48.00 in a...
DocGo’s (DCGO) “Overweight” Rating Reaffirmed at Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of DocGo (NASDAQ:DCGO – Free Report) in a research note released on...
Health Catalyst (NASDAQ:HCAT) Rating Reiterated by Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a report released on...
Truist Financial Boosts Cathay General Bancorp (NASDAQ:CATY) Price Target to $47.00
Cathay General Bancorp (NASDAQ:CATY – Free Report) had its price objective upped by Truist Financial from $45.00 to $47.00 in...